Syros Pharmaceuticals Inc (SYRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 2,833 | 2,954 | -754 | 3,891 | 6,276 |
| Gross Profit | 2,833 | 2,954 | -754 | 3,891 | 6,276 |
| Operating Expenses | 36,833 | 36,166 | 35,243 | 43,345 | 40,045 |
| Operating Income | -34,000 | -33,212 | -35,997 | -39,454 | -33,769 |
| Interest Expense | 1,278 | 1,217 | 1,126 | 1,051 | 981 |
| Other Income | -980 | 10,640 | 32,349 | 10,252 | 269 |
| Pre-tax Income | -36,258 | -23,789 | -4,774 | -30,253 | -34,481 |
| Net Income Continuous | -36,258 | -23,789 | -4,774 | -30,253 | -34,481 |
| Net Income | $-36,258 | $-23,789 | $-4,774 | $-30,253 | $-34,481 |
| EPS Basic Total Ops | -1.30 | -0.85 | 5.11 | -3.21 | -5.40 |
| EPS Basic Continuous Ops | -1.30 | -0.85 | 5.11 | -3.21 | -5.40 |
| EPS Diluted Total Ops | -1.30 | -0.85 | 5.11 | -3.21 | -5.40 |
| EPS Diluted Continuous Ops | -1.30 | -0.85 | 5.11 | -3.21 | -5.40 |
| EPS Diluted Before Non-Recurring Items | -1.30 | -0.85 | -1.28 | N/A | N/A |
| EBITDA(a) | $-33,204 | $-32,439 | $-35,157 | $-38,616 | $-32,915 |